findmyKOL
Clinical trialNCT05979064RecruitingInterventional

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

SponsorNorthwell HealthEnrollment10Brain CancerGBMGlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of BrainGlioma+2 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This single center, single arm, open-label, phase I study will assess the safety of laparoscopically harvested autologous omentum, implanted into the resection cavity of recurrent glioblastoma multiforme (GBM) patients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Lenox Hill Brain Tumor Center

    New York, New York, United States

    Amy McKeown, NPAvraham Zlochower, MDDavid Langer, MDJohn Boockvar, MDNetanel Ben-Shalom, MDOlivia Albers, NPRobert A Andrews, MDTamika Wong, MPHVadim Zhigin, PA-C
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Apr 2023
Primary completion
30 Apr 2027
Completion
30 Apr 2028
Last update posted
1 Jun 2026
Registered enrollment
10
Registry id
NCT05979064

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.